1. BVVLS2 overlooked for 3 years in a pediatric patient caused by novel compound heterozygous mutations in SLC52A2 gene
- Author
-
Chunbao Rao, Jianwei Li, Qi Peng, Ziqiang Liu, and Xiaomei Lu
- Subjects
Male ,Proband ,medicine.medical_specialty ,Anemia ,Hearing Loss, Sensorineural ,Bulbar Palsy, Progressive ,Clinical Biochemistry ,Pure red cell aplasia ,Neurological disorder ,Compound heterozygosity ,Biochemistry ,Gastroenterology ,Receptors, G-Protein-Coupled ,Internal medicine ,medicine ,Humans ,Bulbar palsy ,business.industry ,Biochemistry (medical) ,Membrane Transport Proteins ,General Medicine ,Normocytic anemia ,medicine.disease ,Child, Preschool ,Mutation ,Sensorineural hearing loss ,medicine.symptom ,business - Abstract
Background Brown-Vialetto-Van Laere syndrome-2 (BVVLS2) is a rare autosomal recessive neurological disorder caused by mutations in the SLC52A2 gene, which is characterized by early childhood onset of sensorineural hearing loss, bulbar palsy, peripheral neuropathy, and respiratory insufficiency. We aimed to investigate the genetic cause of a 4-year-old boy who suffered from BVVLS2 whose initial presentation was severe normocytic anemia and had been overlooked for three years in a local hospital. He was misdiagnosed with pure red cell aplasia (PRCA) and treated with hormones and chemotherapy drugs, but there was no obvious effect. Methods The targeted capture of 927 genes associated with neuromuscular disorders and next-generation sequencing were performed. Sanger sequencing was employed to verify the variant mutations. Results The proband was found to be heterozygous for c.350T > C (p.L117P) in exon 3 and c.1135_1137delTGG (p.W379del) in exon 5 of SLC52A2 gene. His anemia and neurological symptoms improved significantly after treatment with low dose oral riboflavin. Conclusions This study expands the mutational spectrum of SLC52A2 and phenotypic spectrum of BVVLS2, which provides a foundation for further investigations elucidating the SLC52A2 related mechanisms of BVVLS2. A low-dosage of riboflavin supplementation was used to obtain good curative effect, which provides further future references for the clinical treatments of BVVLS.
- Published
- 2021
- Full Text
- View/download PDF